The Metabolic Syndrome is Associated with More Aggressive Prostate Cancer |
Ozbek, Emin
(Okmeydani Training and Research Hospital, Department of Urology)
Otunctemur, Alper (Okmeydani Training and Research Hospital, Department of Urology) Dursun, Murat (Bahcelievler State Hospital, Department of Urology) Sahin, Suleyman (Okmeydani Training and Research Hospital, Department of Urology) Besiroglu, Huseyin (Okmeydani Training and Research Hospital, Department of Urology) Koklu, Ismail (Okmeydani Training and Research Hospital, Department of Urology) Erkoc, Mustafa (Okmeydani Training and Research Hospital, Department of Urology) Danis, Eyyup (Okmeydani Training and Research Hospital, Department of Urology) Bozkurt, Muammer (Okmeydani Training and Research Hospital, Department of Urology) |
1 | Kang DI, Chung JI, Ha HK, et al (2013). Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev, 14, 6913-7. 과학기술학회마을 DOI ScienceOn |
2 | Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000). The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev, 21, 215-44. DOI |
3 | Alberti KG, Eckel RH, Grundy SM, et al (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-5. DOI ScienceOn |
4 | Beebe Dimmer JL, Dunn RL, Sarma AV, et al (2007). Features of the metabolic syndrome and prostate cancer in African- American men. Cancer, 109, 875-81. DOI ScienceOn |
5 | Zhou JR, Blackburn GL, Walker WA (2007). Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr, 86, 817-9. DOI |
6 | Teloken C, Da Ros CT, Caraver F, et al (2005). Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol, 174, 2178-80. DOI ScienceOn |
7 | Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem, 266, 37-56. DOI ScienceOn |
8 | Werny DM, Saraiya M, Gregg EW (2006). Prostate-specific antigen values in diabetic and non-diabetic US men, 2001- 2002. Am J Epidemiol, 164, 978-83. DOI ScienceOn |
9 | Parekh N, Lin Y, Marcella S, et al (2008). Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004). Cancer Epidemiol Biomarkers Prev, 17, 2467-72. DOI ScienceOn |
10 | Pandeya DR, Mittal A, Sathian B, Bhatta B (2014). Role of hyperinsulinemia in increased risk of prostate cancer: a case control study from Kathmandu Valley. Asian Pac J Cancer Prev, 15, 1031-3. 과학기술학회마을 DOI ScienceOn |
11 | Pothiwala P, Jain SK, Yaturu S (2009). Metabolic syndrome and cancer. Metab Syndr Relat Disord, 7, 279-88. DOI ScienceOn |
12 | Renehan AG, Zwahlen M, Minder C, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53. DOI ScienceOn |
13 | Rosato V, Zucchetto A, Bosetti C, et al (2011). Metabolic syndrome and endometrial cancer risk. Ann Oncol, 22, 884-9. DOI ScienceOn |
14 | Rosato V, Tavani A, Bosetti C, et al (2011). Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. Metabolism, 60, 1372-8. DOI ScienceOn |
15 | Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. DOI |
16 | LeRoith D, Roberts CT Jr (2003). The insulin-like growth factor system and cancer. Cancer Lett, 195, 127-37. DOI ScienceOn |
17 | Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev, 13, 4097-100. 과학기술학회마을 DOI ScienceOn |
18 | Kim YJ, Cho YJ, Oh JE, et al (2008). The association between metabolic syndrome and prostate-specific antigen levels. Int J Urol, 15, 905-9. DOI ScienceOn |
19 | Kristal AR, Chi C, Tangen CM, et al (2006). Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer, 106, 320-8. DOI ScienceOn |
20 | Laukkanen JA, Laaksonen DE, Niskanen L, et al (2004). Metabolic syndrome and the risk of prostate cancer in Finnish men: a population based study. Cancer Epidemiol Biomarkers Prev, 13, 1646-50. |
21 | Martin RM, Vatten L, Gunnell D, et al (2009). Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control, 20, 1181-92. DOI ScienceOn |
22 | Oliver SE, Gunnell D, Donovan J, et al (2004). Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer, 108, 887-92. DOI ScienceOn |
23 | Ozbek E, Otunctemur A, Dursun M, et al (2014) Association between the Metabolic Syndrome and High Tumor Grade and Stage of Primary Urothelial Cell Carcinoma of the Bladder. Asian Pac J Cancer Prev, 15, 1447-51. 과학기술학회마을 DOI ScienceOn |
24 | Ozbek E, Otunctemur A, Sahin S, et al (2013). Renal cell carcinoma is more aggressive in Turkish patients with the metabolic syndrome. Asian Pac J Cancer Prev, 14, 7351-4. 과학기술학회마을 DOI ScienceOn |
25 | De Nunzio C, Freeland S, Miano R, et al (2011). Meatabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy. Prostate, 71, 1492-8. |
26 | Epstein JI, Allsbrook WC Jr, Amin MB, et al (2005). The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol, 29, 1228-42. DOI ScienceOn |
27 | Buschemeyer WC III, Freedland SJ (2007). Obesity and prostate cancer: Epidemiology and clinical implications. Eur Urol, 52, 331-43. DOI ScienceOn |
28 | Chan JM, Stampfer MJ, Giovannucci E, et al (1998). Plasma insulin-like growth factor-I and pros- tate cancer risk: a prospective study. Science, 279, 563-6. DOI ScienceOn |
29 | Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013). Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8. 과학기술학회마을 DOI ScienceOn |
30 | Hammarsten J, Hogstedt B (2004). Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press, 13, 47-55. DOI ScienceOn |
31 | Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr, 86, 843-57. DOI |
32 | Jeon KP, Jeong TY, Lee SY, et al (2012). Prostate cancer in patients with metabolic syndrome is associated with low grade gleason score when diagnosed on biopsy. Korean J Urol, 53, 593-7. DOI ScienceOn |
33 | Beebe Dimmer JL, Nock NL, Neslund-Dudas C, et al (2009). Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology, 74, 185-90. DOI ScienceOn |
34 | Pelucchi C, Negri E, Talamini R, et al (2010). Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer, 46, 1866-72. DOI ScienceOn |
35 | Platz EA, Leitzmann MF, Rifai N, et al (2005). Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev, 14, 1262-9. DOI ScienceOn |